Ptc Therapeutics PTCT
NASDAQ PTCT
$69.70 -1.70 (-2.38%)
As of: Sep 4, 2026 · 2:33 PM EDT

Ptc Therapeutics (PTCT) Price to Book (2013 - 2026)

Analysis

Ptc Therapeutics (PTCT) Price to Book (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Ptc Therapeutics 5.79 Bn 3.56 Bn 340.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -41.10
Mar 31, 2026 -31.29
Dec 31, 2025 -30.14
Sep 30, 2025 -31.49
Jun 30, 2025 -18.77
Mar 31, 2025 -21.73
Dec 31, 2024 -3.19
Sep 30, 2024 -2.71
Jun 30, 2024 -2.40
Mar 31, 2024 -2.49
Dec 31, 2023 -2.55
Sep 30, 2023 -2.52
Jun 30, 2023 -5.29
Mar 31, 2023 -7.84
Dec 31, 2022 -8.04
Sep 30, 2022 -15.90
Jun 30, 2022 -15.72
Mar 31, 2022 -29.38
Dec 31, 2021 1,961.81
Sep 30, 2021 25.06